views

HeartTransport Systems Market, by Disease Indication (Heart failure,Cardiomyopathy, Congenital Heart Defect, Coronary Heart Disease and Others), byEnd User (Hospitals, Cardiac Centers, and Research Centers), and by Geography(North America, Asia Pacific, Europe, Latin America, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
Heart transport systems aredevices used for maintenance and nourishment of heart while it is beingtransported from harvest in preparation for transplantation. Hearttransportation is a highly critical process as the heart can only be preservedfor around 4 hours in an ice box. Advanced transport systems such as LifeCradleproduct developed by Organ Transport Systems can preserve heart for 12 hours.
The Global Heart Transport System– Market Dynamics
Increasing prevalence ofcardiovascular diseases that often require heart transplant surgeries andgovernment initiatives in funding for research and development in hearttransplant surgeries are major factors driving growth of the global hearttransport systems market. According to The International Society for Heart andLung Transplantation, in 2014, around 586 heart transplant surgeries wereperformed worldwide.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2405
Increasing stress among thepopulace along with sedentary work, high fat intake, and congenital defects inheart also increase demand for heart transplant. This in turn boosts growth ofthe global heart transport systems market.
The Global Heart TransportSystems Market – Regional Insights
North America accounted for thelargest share in the global heart transport systems market in 2017, owing toincreasing number of people diagnosed with coronary artery disease, heartfailure, and cardiomyopathy. According to the U.S. Pediatric CardiomyopathyRegistry, the annual incidence of cardiomyopathy in the U.S. was around 1.13per 10, 00,000 children younger than 18 years of age. Europe accounted for thesecond largest share in the market in terms of revenue, owing to increasingresearch and development activities in heart transport systems. . Market inAsia Pacific is expected to witness the fastest growth, owing to increasinggeriatric population in the region increases prevalence of cardiovasculardisease. For instance, according to a report published by Asia Pacific Journal,in 2018, 7 out of 10 deaths are expected to cause due to cardiovasculardiseases by 2020.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/heart-transport-systems-market-2405
The Global Heart Transport System– Competitive Landscape
Major players operating in theglobal heart transport systems market include, Paragonix Technologies, Inc.,Organ Transport Systems, Pulse Heart Transportation System, and others. Keyplayers in the market are focused on launching new heart transport systems inorder to enhance their market share. For instance, in December 2018, ParagonixTechnologies received approval from the U.S. Food and Drug Administration (FDA)for its Paragonix Sherp, a cardiac transport system.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2405
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737